Skip to content

Physiology and Residual Ischemia After Percutaneous Coronary Intervention

Physiology and Residual Ischemia After Percutaneous Coronary Intervention (EArly Discharge After Transradial Stenting of CoronarY Arteries- EASY- PRIPCI)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04494750
Acronym
EASY-PRIPCI
Enrollment
260
Registered
2020-07-31
Start date
2021-02-18
Completion date
2023-12-31
Last updated
2022-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Pectoris, Chest Pain, Coronary Artery Disease, Coronary Restenosis, Ischemic Heart Disease

Keywords

Coronary Artery Disease, Fractional Flow Reserve (FFR), Coronary physiology, Repeat intervention, diastolic pressure ratio (dPR)

Brief summary

Despite optimal angiographic result after stent implantation, a number of patients will undergo repeat angiography within 1 year of index procedure. EASY-PRIPCI is an observational study evaluating the incidence of abnormal physiology results in patients undergoing repeat angiography after uncomplicated percutaneous intervention (PCI).

Detailed description

Despite successful PCI and complete revascularization, about 25% of patients will present with angina and/or positive exercise testing during follow-up. With recurring or persistent symptoms, a number of those patients will be referred for control angiography. This might create a significant burden for health systems as well as putting patients to undergo further interventions without clear demonstration of ischemia. Assessing physiology and fractional flow reserve in particular after PCI could represent a further step to determine whether stent implantation and stenosis removal will be effective to relieve subjective and objective signs of ischemia. Hypothesis: Resting gradients such as whole cycle Pd/Pa and diastolic dPR and FFR will be abnormal (below ischemic threshold) in \> 20% of cases despite optimal stent implantation and angiographic result. The use of physiology assessment in previously intervened vessels in patients referred for persisting or recurring angina might help operators to decide upon further intervention.

Interventions

None listed

Sponsors

Quebec Heart Institute
CollaboratorOTHER
Laval University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient referred for diagnostic angiography and possible PCI within 12 months of uncomplicated PCI with stent implantation.

Exclusion criteria

* Unable to understand study design or objectives of study. * Unable to sign informed consent. * Evidence of in-stent restenosis or significant untreated coronary lesions (initial incomplete revascularization) * Inability to comply with the study follow-up

Design outcomes

Primary

MeasureTime frameDescription
Rate of successful uncomplicated PCI as per coronary physiology ratiosTransprocedural, initial and final valuesRecord the minimal values reported for Pd/Pa, dPR and FFR ratios in the distal vessel after uncomplicated PCI and good angiographic result.Comparison between baseline (pre PCI) and final (post PCI) coronary physiology ratios .

Secondary

MeasureTime frameDescription
Incidence and types of further interventions or imaging techniquesHistorical and immediately after the procedure, up to 36 monthsRecord the incidence by type of intervention and diagnostic or imaging techniques
Residual symptoms and quality of life after repeat angiographyup to 30 daysIdentify residual symptoms after intervention, and overall immediate quality of life.
Rates of repeat interventionsHistorical and immediately after the procedureon previously intervened lesions versus PCI on new lesions
Incidence of successful distal positioning of pressurewireTransprocedural

Countries

Canada

Contacts

Primary ContactOlivier F. Bertrand, MD, PhD
olivier.bertrand@chul.ulaval.ca+14186568711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026